- Home
- MOVE vs OSRH Comparison
MOVE vs OSRH Comparison
Compare MOVE & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MOVE | OSRH |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | 21 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 901.4M | 11.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | MOVE | OSRH |
|---|---|---|
| Price | $14.25 | $0.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 96.5K | ★ 794.0K |
| Earning Date | 04-08-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $433,000.00 | N/A |
| Revenue This Year | $1,460.71 | $9.30 |
| Revenue Next Year | $96.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $0.38 |
| 52 Week High | $34.87 | $1.79 |
Technical Indicators
Market Signals| Indicator | MOVE | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 53.81 | 56.35 |
| Support Level | $6.77 | $0.42 |
| Resistance Level | $15.51 | $0.60 |
| Average True Range (ATR) | 2.67 | 0.07 |
| MACD | 0.13 | 0.00 |
| Stochastic Oscillator | 50.71 | 59.85 |
Price Performance
Historical ComparisonAbout MOVE Movano Inc.
Corvex Inc is an AI cloud computing company specializing in GPU accelerated infrastructure for AI workloads. The company provides AI-focused computing infrastructure that offers scalable computational resources. Its platform uses GPU-accelerated compute clusters and high-throughput storage to support performance, security, and efficiency at scale. The company's product portfolio includes GPU Clusters, Inference-as-a-Service, Confidential Computing, and GPU Node.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.